Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
Clinical trial NCT06417775 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06417775
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-10
- Primary completion
- 2027-11-01
- Enrollment
- 496
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.